Msn - Profile
✉ Email this page to a colleague
Drugs and US Patents for Msn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 209878-003 | Nov 20, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | LEVETIRACETAM | levetiracetam | SOLUTION;ORAL | 214757-001 | Jul 15, 2022 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 211933-002 | Feb 8, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | VIGABATRIN | vigabatrin | FOR SOLUTION;ORAL | 215363-001 | Sep 7, 2022 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |